Downgrading skin climacteric aging by hormone replacement therapy

References

• Viscoli CM, Brass LM, Kerman WN, Sarrel PM, Suissa S, Horwitz RI. A clinical trial of estrogen replacement therapy after ischemic stroke. N. Engl. J. Med.345, 1243–1249 (2001).
   PubMed Web of Science ®Google Scholar
• Grady D, Herrington D, Bittner V et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and Estrogen/Progestin Replacement Study follow-up (HERS II). JAMA288, 49–57 (2002).
   PubMed Web of Science ®Google Scholar
• The Women’s Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA291, 1701–1712 (2004).
   PubMed Web of Science ®Google Scholar
• Scarabin PY, Oger E, Plu Bureau G. Differential association of oral and transdermal estrogen replacement therapy with venous thromboembolism risk. Lancet362, 428–432 (2003).
   PubMed Web of Science ®Google Scholar
• Fournier A, Berrino F, Riboli E, Avenel V, Clavel-Chapelon F. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int. J. Cancer114, 448–454 (2004).
   Web of Science ®Google Scholar
• Piérard GE. The quandary of climacteric skin ageing. Dermatology193, 273–274 (1996).
   PubMed Web of Science ®Google Scholar
• Quatresooz P, Piérard-Franchimont C, Gaspard U, Piérard GE. Skin climacteric aging and hormone replacement therapy. J. Cosmet. Dermatol.5, 3–8 (2006).
   Google Scholar
• Raine-Fenning NJ, Brincat M, Muscat-Baron Y. Skin ageing and menopause: implications for treatment. Am. J. Clin. Dermatol.4, 371–378 (2003).
   PubMed Web of Science ®Google Scholar
• Sauerbronn AV, Fonseca AM, Bagnoli VR, Saldiva PH, Pinotti JA. The effect of systemic hormonal replacement therapy on the skin of postmenopausal women. Int. J. Gynaecol. Obstet.68, 35–41 (2000).
   PubMed Web of Science ®Google Scholar
• Oikarinen A. Systemic estrogens have no conclusive beneficial effect on human skin connective tissue. Acta Obstet. Gynecol. Scand.79, 250–254 (2000).
   PubMed Web of Science ®Google Scholar
• Hermanns-Lê T, Uhoda I, Smitz S, Piérard GE. Skin tensile properties revisited during ageing. Where now, where next? J. Cosmet. Dermatol.3, 35–40 (2004).
   Google Scholar
• Castelo-Branco C, Figueras F, Martinez de Osaba MJ, Vanrell JA. Facial wrinkling in postmenopausal women. Effects of smoking status and hormone replacement therapy. Maturitas29, 75–86 (1998).
   PubMed Web of Science ®Google Scholar
• Piérard-Franchimont C, Cornil F, Dehavay J, Letot B, Deleixhe-Mauhin F, Piérard GE. Climacteric skin ageing of the face. A prospective longitudinal intent-to-treat trial on the effect of oral hormone replacement therapy. Maturitas32, 87–93 (1999).
   PubMedGoogle Scholar
• Henry F, Quatresooz P, Valverde-Lopez JC, Piérard GE. Blood vessel changes during pregnancy. A review. J. Cosmet. Dermatol.7, 65–69 (2006).
   Google Scholar
• Margolis DJ, Knauss J, Bilker W. Hormone replacement therapy and prevention of pressure ulcers and venous leg ulcers. Lancet359, 675–677 (2002).
   PubMed Web of Science ®Google Scholar
• Castello-Branco C, Pons F, Gratacos E, Fortuny A, Vanrell JA, Gonzales-Merlo J. Relationship between skin collagen and bone changes during aging. Maturitas18, 199–206 (1994).
   Google Scholar
• Shah MG, Maibach HI. Estrogen and skin: an overview. Am. J. Clin. Dermatol.2, 143–150 (2001).
   PubMedGoogle Scholar
• Piérard GE, Vanderplaetsen S, Piérard-Franchimont C. Comparative effect of hormone replacement therapy on bone mass density and skin tensile properties. Maturitas40, 221–227 (2001).
   PubMed Web of Science ®Google Scholar
• Piérard GE, Piérard-Franchimont C, Vanderplaetsen S, Franchimont N, Gaspard U, Malaise M. Relationships between bone mass density and tensile strength of the skin in women. Eur. J. Clin. Invest.31, 731–735 (2001).
   PubMed Web of Science ®Google Scholar
• Piérard-Franchimont C, Letawe C, Goffin V, Piérard GE. Skin water-holding capacity and transdermal estrogen therapy for menopause: a pilot study. Maturitas22, 151–154 (1995).
   PubMed Web of Science ®Google Scholar
• Paquet F, Piérard-Franchimont C, Fumal I, Goffin V, Paye M, Piérard GE. Sensitive skin at menopause; dew point and electrometric properties of the stratum corneum. Maturitas28, 221–227 (1998).
   PubMed Web of Science ®Google Scholar
• Roux C. Randomised, double-masked, 2 years comparison of tibolone with 17β estradiol and norethindrone acetate in preventing postmenopausal bone loss. Osteoporosis Int.13, 241–248 (2002).
   PubMed Web of Science ®Google Scholar
• Piérard-Franchimont C, Piérard GE. Post-menopausal aging of the sebaceous follicle. A comparison between women receiving hormone replacement therapy or not. Dermatology204, 17–22 (2002).
   PubMed Web of Science ®Google Scholar
• Callens A, Vaillant L, Lecomte P, Berson M, Gall Y, Lorette G. Does hormonal skin aging exist? A study of influence of different hormone therapy regimens on the skin of postmenopausal women using non-invasive measurement techniques. Dermatology193, 189–291 (1996).
   Google Scholar
• Guinot C, Malvy D, Ambroisine L et al. Effect of hormonal replacement therapy on skin biophysical properties of menopausal women. Skin Res. Technol.11, 201–204 (2005).
   Google Scholar
• Wines N, Willsteed E. Menopause and the skin. Austral. J. Dermatol.42, 149–160 (2001).
   PubMedGoogle Scholar